TVTtraining__培训课件.ppt

GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * Postoperatively, the patient is observed for signs of bleeding. There are no restrictions on eating and drinking, and the patient is encouraged to void normally. At this point please reference the Postoperative Care page in the Preceptee Binder. GYNECARE TVT * Residual urine is measured to rule out retention. Prophylactic antibiotics are prescribed according to local practice.. Post-operatively the patient is instructed to restrict their normal activity for one or two weeks depending of job content. She is recommended to refrain from heavy exercise ( i.e.. Cycling, jogging, and lifting) for at least three to four weeks. Refrain from intercourse for one month. GYNECARE TVT * After an initial follow-up at 3 weeks, patients are seen at 6 months and annually. GYNECARE TVT * Please review the Warnings and Precautions section of the Preceptee binder at this point. The adverse reactions should also be reviewed. Urinary retention should be address according to local practice. GYNECARE TVT * Perforation of the bladder will be identified cystoscopically. The introducer needle should be removed and replaced where it does not impinge on the urinary tract. An indwelling catheter is placed and left to drainage for 1-2 days. GYNECARE TVT * Bleeding occasionally occurs and is limited by the retropubic space. This can usually be successfully managed with a vaginal pack, although Percutaneous drainage may be necessary. GYNECARE TVT * Infection is managed with appropriate antibiotics. GYNECARE TVT * GYNECARE TVT * A large number of patients have undergone the procedure since 1995, verifying that the procedure is safe. Follow-up at 2 years indicates 84% cure. The procedure is safe and effective. All recent peer reviewed clinical studies are included in the Preceptee binders. GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GYNECARE TVT * GY